Incyte Corporation and MacroGenics, Inc. entered into a global collaboration and license agreement for MacroGenics’ MGA012. MGA012 is amonoclonal antibody that inhibits programmed cell death protein 1 that shows potential in cancer treatment.
UD President Dennis Assanis estimated that when all is said and done, the combination of a new $150 million-plus building as well as public and private funded could add up to a half a billion-dollar impact.
The Medical Society of Delaware through its subsidiary “Health Hub,” has partnered with MEND VIP, Inc. (MEND) to offer telemedicine and patient engagement platform to all MSD members.
The News Journal of Wilmington reports that the six-story, 200,000-square-foot (18580.45-sq. meter) building on which construction will begin Monday is unique in that the university will finance it without state or government grants and will be the owner. With previous developments, the university leased the space and a private company constructed the building.
Christiana Care Health System has announced that scientists at its Center for Translational Cancer Research within the Helen F. Graham Cancer Center & Research Institute have developed a new blood test for diagnosing breast cancer.
Delawareans who attended the Chincoteague Chili Chowder Cook-Off, in Chincoteague, VA, on September 30, are being asked to complete an online survey following a...
Delaware opened its first medical marijuana dispensary, the First State Compassion Center, in Wilmington in 2015. First State also won the contract for a dispensary in Sussex County, which opened this past May.
Saint Francis Healthcare has been designated as a Level III Trauma Center by the American College of Surgeons Verification Review Committee.
The Chemours Company announced that its President and CEO, Mark Vergnano, has been elected to chair the...
Gov. John Carney is urging Delawareans to get outside and enjoy the great outdoors.